About Revolver Therapeutics
Revolver Therapeutics develops peptide therapeutics using a screening platform to target transcription factors for cancer treatment.
Sectors & Market Categories
Company Details
Corporate & Operational Profile
Primary Industry
Biotech & Healthcare
Funding Stage
Pre-Seed
Global Headquarters
Bath, United Kingdom
Tracked Since
Oct 2, 2026
Web & Domain Identity
Official Website
revolvertherapeutics.com
Domain Registered Date
Jun 2, 2025
Social & Network Presence
X / Twitter Profile
Not linked
LinkedIn Corporate
Not linked
Company Milestones & Timeline
- Capital Raise
Raised $763,334 · Pre-Seed
University of Bath
- Milestone
Website domain registered
revolvertherapeutics.com
Investors & Backers
Investor firms and individual backers were not publicly disclosed in available round filings for Revolver Therapeutics.
Funding History
Pre-Seed
· Jul 3, 2026
$763,334 University of Bath
Founders & Leadership
Jody Mason
Founder & CSO
Work email & phone locked
Unlock →
Press Coverage & Sources
Recently Funded Biotech & Healthcare Startups
View allVitalls
vitalls.ai
Seed Abu Dhabi, United Arab Emirates · Oct 2026
Hexagon Bio
hexagonbio.com
Series-B+ Oct 2026
RefloDx
reflodx.com
Seed Kaysville, United States · Oct 2026
HeyVoli
heyvoli.com
Pre-Seed Bangalore, India · Oct 2026
CureBay
curebay.com
Series-B+ Bhubaneshwar, India · Oct 2026
4Tissue
4tissue.com
Series-A Ghent, Belgium · Oct 2026